BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 28321840)

  • 1. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
    Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
    J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Stroke-Associated Pneumonia With Acid-Suppressive Drugs: A Population-Based Cohort Study.
    Ho SW; Hsieh MJ; Yang SF; Yeh YT; Wang YH; Yeh CB
    Medicine (Baltimore); 2015 Jul; 94(29):e1227. PubMed ID: 26200649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based cohort study on the risk of pneumonia in patients with non-traumatic intracranial haemorrhage who use proton pump inhibitors.
    Ho SW; Tsai MC; Teng YH; Yeh YT; Wang YH; Yang SF; Yeh CB
    BMJ Open; 2014 Nov; 4(11):e006710. PubMed ID: 25384687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
    Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
    PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
    Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
    Wu CL; Lei WY; Wang JS; Lin CE; Chen CL; Wen SH
    PLoS One; 2020; 15(11):e0242975. PubMed ID: 33253311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease.
    Chen CH; Lin HC; Lin HL; Lin YT; Chou JM; Hsu SP; Fung CP
    J Microbiol Immunol Infect; 2015 Aug; 48(4):390-6. PubMed ID: 24291618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
    Song TJ; Kim J
    PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
    McCaleb RV; Gandhi AS; Clark SM; Clemmons AB
    Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Uncertainty of the Association Between Proton Pump Inhibitor Use and the Risk of Dementia: Prescription Sequence Symmetry Analysis Using a Korean Healthcare Database Between 2002 and 2013.
    Park SK; Baek YH; Pratt N; Kalisch Ellett L; Shin JY
    Drug Saf; 2018 Jun; 41(6):615-624. PubMed ID: 29397553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Nationwide Population-Based Cohort Study of Dementia Risk Among Acid Suppressant Users.
    Hwang IC; Chang J; Park SM
    Am J Geriatr Psychiatry; 2018 Nov; 26(11):1175-1183. PubMed ID: 30072307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
    Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
    Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
    J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
    Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
    PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.
    Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC
    Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.